The deal with Walgreens is likely to enhance sales of Veeva Data Cloud products including Veeva OpenData, Link, and Compass products. This partnership benefits Veeva Systems by expanding its reach ...
Veeva Systems is executing well its migration plan from Salesforce to Veeva Vault CRM, positioning itself for double-digit revenue growth. Better than expected Q2 2023 results with revenue of $590.2 ...
This leading provider of cloud-based software solutions is well-positioned to benefit from the life sciences industry's steady growth. However, it turns out Veeva was far from immune to the economic ...
Veeva previously faced restrictions on integrating IQVIA’s industry-leading data into its commercial products, such as Veeva Network and Nitro, which limited competitiveness. The company has now ...
Veeva Systems focuses on providing cloud software and applications for the life sciences industry, including pharmaceuticals and biotech companies, making it unique in the market. Key growth drivers ...
Zacks Investment Research on MSN
Reasons to hold Veeva Systems stock in your portfolio for now
Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...
Veeva Systems is a leading global provider of cloud software solutions for life sciences companies such as drugmakers, biotech companies and medical device makers. The company is steadily growing ...
Veeva Systems (VEEV) delivered strong third-quarter results, beating revenue and earnings estimates while sharing an upbeat outlook for the rest of the fiscal year. The company is highlighting ...
Top-line growth rates at the cloud computing company have dropped recently. Still, Veeva's prospects remain intact for investors focused on the long game. The life sciences-focused, cloud-based ...
NEW YORK & PLEASANTON, Calif.--(BUSINESS WIRE)--Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) ...
Veeva delivered 16% revenue growth and $2.04 adjusted EPS for its third fiscal quarter. Both came ahead of guidance by low- and midsingle digits, respectively, and full-year guidance was raised by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results